Bioassays
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Resolian
PAO-11-24-RTM-04Nov 12, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10Sep 17, 2024
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4Jan 24, 2024
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
Amy Sheng, Ph.D.; Xuejiao Zhang, Ph.D.; Yingmin Zhu, Ph.D.
Sino Biological
PAO-09-23-CL-01Aug 31, 2023
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Kristen M. Eisenhauer; Mark Mintz
Charles River Laboratories
PAO-05-23-CL-03May 5, 2023
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05Feb 1, 2023
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
Sumana Sundaramurthy, Ph.D.
Sino Biological
PAO-11-022-CL-15Jan 10, 2023
Computational Drug Design
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
Ronald Dorenbos, Ph.D.; Guido Lanza
Charles River Laboratories
PAO-11-022-CL-11-180Dec 7, 2022
Multispecific Antibodies
Optimized Multispecific Antibody Design, Development, and Manufacturing
Sino Biological
PAO-08-022-CL-04Aug 22, 2022
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
Rob Burgess, Ph.D.; Lilith Elmore; Amy Sheng, Ph.D.
Sino Biological
PAO-04-022-CL-01Apr 7, 2022
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01Mar 11, 2021
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01Feb 4, 2021
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Ron Laethem, Ph.D.
Altis Biosystems
PAO-11-20-CL-01Dec 9, 2020
Drug Discovery
A Research Partner With Proven Results
Daniel Conlon
IRBM
PAP-Q1-2019-CL-038Mar 12, 2019